Cargando…

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation

INTRODUCTION: SARS-CoV-2 has developed a number of Variants of Concern (VOC) with increased infectivity and/or reduced recognition by neutralizing antibodies specific for the receptor binding domain (RBD) of the spike protein. Extended studies of other viruses have shown that strong and broad viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Xinyue, Liu, Xuelan, Martina, Byron, Zeltins, Andris, Augusto, Gilles, Vogel, Monique, Mohsen, Mona O., Speiser, Daniel E., Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950740/ https://www.ncbi.nlm.nih.gov/pubmed/36845100 http://dx.doi.org/10.3389/fimmu.2023.1114396

Ejemplares similares

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
por: Chang, Xinyue, et al.
Publicado: (2022)

Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction
por: Vogel, Monique, et al.
Publicado: (2021)

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
por: Chang, Xinyue, et al.
Publicado: (2021)

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
por: Augusto, Gilles, et al.
Publicado: (2021)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
por: Chang, Xinyue, et al.
Publicado: (2021)

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
por: Zha, Lisha, et al.
Publicado: (2021)

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mohsen, Mona O., et al.
Publicado: (2021)

Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism
por: Bachmann, Martin F., et al.
Publicado: (2022)

A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021)

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
por: Liu, Xuelan, et al.
Publicado: (2021)

Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity
por: Chang, Xinyue, et al.
Publicado: (2021)

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021)

Intranasal administration of a VLP‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
por: Rothen, Dominik A., et al.
Publicado: (2022)

Construction and Characterization of Virus-Like Particles: A Review
por: Zeltins, Andris
Publicado: (2012)

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
por: Mohsen, Mona O., et al.
Publicado: (2020)

Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion
por: Albright, Catherine, et al.
Publicado: (2023)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation
por: Ogrina, Anete, et al.
Publicado: (2022)

Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
por: Ogrina, Anete, et al.
Publicado: (2023)

Hepatitis A Virus Vaccine Escape Variants and Potential New Serotype Emergence
por: Pérez-Sautu, Unai, et al.
Publicado: (2011)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

On the role of allergen-specific IgG subclasses for blocking human basophil activation
por: Zinkhan, Simon, et al.
Publicado: (2022)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2023)

On Iron Metabolism and Its Regulation
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2021)

An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2021)

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
por: Starr, Tyler N., et al.
Publicado: (2021)

Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants
por: Chakraborty, Sandipan, et al.
Publicado: (2022)

On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
por: Plattner, Kevin, et al.
Publicado: (2023)

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
por: Mohsen, Mona O, et al.
Publicado: (2022)

Variants of Streptococcus pneumoniae Serotype 14 from Papua New Guinea with the Potential to Be Mistyped and Escape Vaccine-Induced Protection
por: Manna, Sam, et al.
Publicado: (2022)

Active vaccination against interleukin‐5 as long‐term treatment for insect‐bite hypersensitivity in horses
por: Fettelschoss‐Gabriel, Antonia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f04bh6dm29lp406gmpbkpks2fq